Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Q1 Conference
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by Breakthoroughon May 12, 2021 9:11am
274 Views
Post# 33181446

RE:Q1 Conference

RE:Q1 Conference Don't get your point...: Selected Upcoming Milestones Maveropepimut-S Q2 2021: Beginning of Phase 2B DLBCL trial Q2 2021: Translational and biomarker clinical update for ovarian cancer Q3 2021: Initiation of investigator-led study in breast cancer H2 2021: Meeting with FDA and final design for next clinical study in ovarian cancer H2 2021: Clinical update basket trial H1 2022: Clinical update Phase 2B DLBCL trial DPX-SurMAGE H2 2021: Initiation of a Phase 1 clinical study in bladder cancer
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities